Huawei Technologies is in talks to sell its premium smartphone brands P and Mate to a group led by Shanghai government-backed investment firms, which could signal the start of the company's exit from high-end smartphone-manufacturing.
According to sources, the Shanghai government-backed investment firms may form a consortium with Huawei’s dealers to take over the P and Mate brands.
They added the Huawei will likely send the management team for premium smartphone brands team to work for the new entity.
Shipments of Mate and P Series phones were worth $39.7 billion between Q3 2019 and Q3 2020, according to consultancy IDC.
Huawei, the biggest telecoms equipment vendor in the world and No.2 smartphone manufacturer, began exploring the possibility of selling the brands last September.
However, Huawei has not made a final decision on the sale as the company is still trying to manufacture its in-house designed high-end Kirin chips which power its smartphones.
A Huawei spokesman called the news of the possible sale of our flagship smartphone brands unsubstantiated rumors.
Huawei’s plan to sell its premium smartphone lines suggests it does not believe that the Biden administration will have a change of heart towards the supply chain restrictions placed on them since May 2019.
last November, Huawei announced the sale of its budget phone brand Honor to a consortium of 30 dealers led by a Shenzhen government-backed company. The all-cash sale fetched over $15.5 billion.


Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Trump Urges Iran to Sign Nuclear Deal Amid Ongoing Conflict and Port Blockade
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
BOJ Governor Kazuo Ueda Hints at Rate Hike as Inflation Pressures Build
Gold Prices Drop Amid Iran War Concerns, Rising Oil Costs, and Hawkish Central Bank Signals
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Trump-Iran Conflict Escalates as Nuclear Talks Stall and Oil Prices Surge
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Asian Stocks Mixed as BOJ Holds Rates, Oil Prices and Fed Outlook Weigh on Markets
China Factory Activity Extends Growth in April Despite Global Pressures
Gold Prices Dip Ahead of Fed Decision Amid Rising Middle East Tensions
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand 



